AlertEdge.io
Single-Ticker Trade Brief
UNH — UnitedHealth Group Report Date: 2026-10-20 17:43 UTC  |  Sector: Health Care  |  Rating:
RISK DISCLAIMER: This is an automated breakout signal. Always validate before entering a position.
▲ Breakout Signal — Volume Confirmed

UNH closed above the $418.63 breakout level on 1.21x average volume. ATR-based levels set automatically. Next resistance target: $444.91.

Ticker
UNH
Entry Price
$421.69
Breakout Level
$418.63
Stop Loss
$407.02
TP1 Target
$444.91
TP2 Target
$460.39
Risk / Reward
1 : 1.58
1.21x avg volume
View UNH Chart on TradingView

Key Price Levels

TP1 Target
$444.91
Breakout Level
$418.63
Entry
$421.69
Stop Loss
$407.02

Fundamentals

P/E Ratio
N/A
EPS (TTM)
N/A
Dividend Yield
0%
52-Wk High
N/A
52-Wk Low
N/A
Beta
N/A

Deep Dive Analysis — Claude Sonnet

TRADE BRIEF — UNH (UnitedHealth Group)

Generated by AlertEdge.io

SETUP

UNH cleared the $418.63 breakout level intraday, closing near session highs at $421.69 with volume running 1.21x average. The bar structure shows a clean push off the open with a tight low at $417.86, suggesting buyers absorbed early supply quickly. The breakout level held as intrabar support, which is a constructive sign. TP1 sits at $444.91 and TP2 at $460.39, offering a defined path higher with a stop at $407.02. The R/R of 1:1.58 is acceptable but not exceptional.

CATALYSTS

UNH is a bellwether in managed care, and any rotation into defensive health care names during macro uncertainty would benefit it directly. The company is a major beneficiary of Medicare Advantage enrollment trends and typically carries pricing power heading into annual enrollment periods. Watch for any sector-wide tailwinds tied to policy clarity around insurance reimbursement rates or CMS announcements. Earnings are a potential catalyst but timing relative to this trade must be confirmed before sizing up.

RISKS

Fundamentals are unavailable in this signal, which is a meaningful gap. Without P/E, EPS, or 52-week range data, valuation risk cannot be assessed. UNH has faced significant headline risk in recent months related to the UnitedHealthcare CEO shooting, reputational damage, and political scrutiny of the managed care industry. Regulatory pressure on prior authorizations and potential Medicare Advantage rate cuts remain structural headwinds. A failure to hold $418.63 on any retest would invalidate the breakout immediately. The signal quality score of 50 out of 100 is a concern, suggesting this may be a technically extended entry rather than an early-stage move.

CONVICTION: Low

The combination of a mediocre signal quality score of 50, missing fundamental data, unresolved regulatory and reputational overhangs on UNH specifically, and a R/R that barely clears 1.6x does not justify high confidence in this setup at current levels.